Results 161 to 170 of about 63,889 (276)

Enhancing Bioavailability of Ultra-High Concentration Antibody Formulations Using Ionic Liquids. [PDF]

Adv Healthc Mater
Ramesh A, Erdi M, Zhang S, Suja VC, Mitragotri S, Singh B.   +5 more
europepmc   +1 more source

Ziekenhuisopname verhoogt Kosten voor Infliximab bij Crohn

, 2003
This paper presents a cost analysis of the utilisation of infliximab for the treatment of Crohn's disease. The indication for infliximab for Dutch Crohn patients is an active disease with insufficient improvement on adequate therapy with corticosteroids ...
Heijman, J.A., Smits, S.R.J.G., Van Dullemen, H.M., Brouwers, J.R.B.J., Postma, M.J., Rutten, W.J.M.J.   +5 more
core  

Dissecting Cellulitis and Hidradenitis Suppurativa: Two Diseases or One Follicular‐Occlusion Spectrum?

International Journal of Dermatology, EarlyView.
Graphical abstract summarizing evidence that dissecting cellulitis of the scalp (DC) and hidradenitis suppurativa (HS) may represent site‐modified expressions of a shared follicular‐occlusion pathway, highlighting convergent clinical, histopathologic, and therapeutic features, the diagnostic‐context paradox, and the need for paired molecular studies ...
Giuseppe Gallo, Federica Repetto, Orsola Crespi, Isotta Giunipero di Corteranzo, Luca Mastorino, Pietro Quaglino, Simone Ribero   +6 more
wiley   +1 more source

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies. [PDF]

Diabetes Care
Chen LR, Cooksley T, Kochhar R, Titus Raj EJ, Lorigan P, Adam S.   +5 more
europepmc   +1 more source

Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience

Internal Medicine Journal, EarlyView.
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop, Tanya Ravipati, Steven Mileto, Eugene Athan, Dena Lyras, Ravindranath Tiruvoipati   +5 more
wiley   +1 more source

A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy. [PDF]

Clin Case Rep
Ibrahim M, Dulay MS, Wechalekar K, Kouranos V, Sharma R.   +4 more
europepmc   +1 more source

Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

Immunology, EarlyView.
PSTPIP2 acts as a key brake on myeloid inflammation by suppressing IL‐1β‐driven signalling, macrophage dysregulation and inflammation‐associated bone remodelling. Its emerging roles in CRMO/CMO, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid support its potential as a biomarker and therapeutic target.
Erdong Zhang, Fengyu Liu, Yongle Wei, Guoqiang Li, Liujie Zheng, Lin Jin, Feng Luan, Yingze Zhang, Ling Wang, Zhiyong Hou   +9 more
wiley   +1 more source

Stability of infliximab serum concentrations during long-term frozen storage: a paired biobank study. [PDF]

J Crohns Colitis
Anjie SI, van Zon S, Bloem K, Rispens T, D'Haens GR.   +4 more
europepmc   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study. [PDF]

Crohns Colitis 360
Vuijk SA, Klomberg RCW, Katgert E, Wessels MMS, Miele E, Cameron FL, Milovanovich ID, Muhammed R, Devadason D, Hart J, Rizopoulos D, Croft NM, de Ridder L, PIBD-SETQuality Consortium, PIBD-SETQuality Consortium .   +14 more
europepmc   +1 more source